Baxter International Inc stock page - price, fundamentals, dividends - iOCharts

BAX

79.68
+1.50 (1.92%)
Baxter International Inc (NYSE, USD)
Healthcare >
Medical Instruments & Supplies
Market cap
40.07B
Ent value
47.86B
Price/Sales
3.43
Price/Book
4.72
Div yield
1.41%
Div growth
3.74%
Growth years
4
FCF payout
40.81%
Trailing P/E
36.39
Forward P/E
19.82
PEG
3.76
EPS growth
13.20%
1 year return
-1.86%
3 year return
3.23%
5 year return
10.96%
10 year return
10.23%
Last updated: 2021-10-19

STOCK INFORMATION

Stock chart

Loading...
Stock price data
Open78.44
Daily high79.73
Daily low78.39
Daily Volume2.15M
All-time high94.14
1y analyst estimate94.00
Beta0.68
EPS (TTM)2.18
Dividend per share1.12
Ex-div date2 Sep 2021
Next earnings date28 Oct 2021

Downside potential

Loading...
Downside potential data
BAXS&P500
Current price drop from All-time high-15.36%-0.56%
Highest price drop-68.86%-56.47%
Date of highest drop1 Apr 20039 Mar 2009
Avg drop from high-16.07%-11.45%
Avg time to new high26 days12 days
Max time to new high1406 days1805 days

DIVIDENDS

Dividend yield - 5y

Loading...
Dividend yield data
Dividend per share1.12
Dividend yield1.41%
Payout frequencyQuarterly
Maximum yield1.52%
Average yield1.13%
Minimum yield0.89%
Discount to avg yield19.59%
Upside potential24.37%
Yield as % of max yield92.58%

Yield distribution (inverse percentile) - 5y

Loading...
Yield distribution data
Dividend yield1.41%
Current yield distribution2.30%
Yield at 100% (Min)0.89%
Yield at 90%1.00%
Yield at 80%1.02%
Yield at 50% (Median)1.12%
Yield at 20%1.22%
Yield at 10%1.28%
Yield at 0% (Max)1.52%

Dividend per share

Loading...
Dividend per share data
Years of growth4 years
CCC status-
Dividend per share1.12
Payout frequencyQuarterly
Ex-div date2 Sep 2021
EPS (TTM)2.18
EPS (1y forward)4.02
EPS growth (5y)13.20%
EPS growth (5y forward)9.67%

Dividend growth

Loading...
Please create a free account or log in to access this chart
Dividend growth data
BAXS&P500
DGR MR14.29%7.68%
DGR TTM12.90%-2.66%
DGR 3 years16.12%5.82%
DGR 5 years3.74%6.23%
DGR 10 years4.07%9.64%
DGR 15 years7.65%6.71%
Time since last change announced170 days
EPS growth (5y)13.20%
EPS growth (5y forward)9.67%

Payout ratio

Loading...
Please create a free account or log in to access this chart
Payout ratio data
EPS coverageFCF coverage
TTM42.96%40.81%
Average--
Forward27.86%-

VALUATION

Valuation Ratios

Loading...
Valuation Ratios data
Trailing P/E36.39
Price to OCF21.45
Price to FCF34.57
Price to EBITDA18.94
EV to EBITDA22.63

Valuation (Sales/Book Value)

Loading...
Valuation (Sales/Book Value) data
Price to Sales3.43
Price to Book4.72
EV to Sales4.10

FINANCIALS

Per share

Loading...
Per share data
Current share count502.85M
EPS (TTM)2.18
FCF per share (TTM)2.30

Income statement

Loading...
Income statement data
Revenue (TTM)11.67B
Gross profit (TTM)4.59B
Operating income (TTM)1.57B
Net income (TTM)1.10B
EPS (TTM)2.18
EPS (1y forward)4.02

Margins

Loading...
Margins data
Gross margin (TTM)39.30%
Operating margin (TTM)13.46%
Profit margin (TTM)9.43%

Balance Sheet

Loading...
Please create a free account or log in to access this chart
Balance Sheet data
Cash3.18B
Net receivables1.92B
Total current assets7.86B
Goodwill3.11B
Intangible assets1.96B
Property, plant and equipment5.18B
Total assets19.47B
Accounts payable1.02B
Short/Current long term debt6.09B
Total current liabilities3.19B
Total liabilities10.98B
Shareholder's equity8.49B
Net tangible assets3.38B

Cash flow

Loading...
Please create a free account or log in to access this chart
Cash flow data
Operating cash flow (TTM)1.87B
Capital expenditures (TTM)709.00M
Free cash flow (TTM)1.16B
Dividends paid (TTM)473.00M

Financial returns

Loading...
Please create a free account or log in to access this chart
Financial returns data
Return on Equity12.62%
Return on Assets5.50%
Return on Invested Capital7.38%
Cash Return on Invested Capital7.77%
COMPANY DETAILS
BAX (Baxter International Inc) company logo
Marketcap
40.07B
Marketcap category
Large-cap
Description
Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; renal replacement therapies and other organ support therapies focused in the intensive care unit; sterile intravenous (IV) solutions, IV therapies, infusion pumps, administration sets, and drug reconstitution devices; and parenteral nutrition therapies. It also provides biological products and medical devices, and surgical hemostat and sealant products used in surgical procedures for hemostasis, tissue sealing, and adhesion prevention; premixed and oncology drug platforms, inhaled anesthesia and critical care products, and pharmacy compounding services; and generic injectable pharmaceuticals. Its products are used in hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, doctors' offices, and patients at home under physician supervision. The company sells its products through direct sales force, as well as through independent distributors, drug wholesalers, and specialty pharmacy or other alternate site providers in approximately 100 countries. It has an agreement with Celerity Pharmaceutical, LLC to develop acute care generic injectable premix and oncolytic molecules. Baxter International Inc. was founded in 1931 and is headquartered in Deerfield, Illinois.
Employees
50000
Investor relations
SEC filings
CEO
Jose Almeida
Country
USA
City
Deerfield
Stock type
Common stock
CCC status
-
Dividend Frequency
Quarterly
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
All newsPress releases
October 13, 2021
DEERFIELD, Ill., October 13, 2021--Baxter International Inc. (NYSE:BAX), a leading global medical products company, will present at the Credit Suisse 30th Annual Virtual Healthcare Conference on Monda...
October 12, 2021
Intuitive Surgical's (ISRG) third-quarter results are likely to reflect solid performance at the Instruments & Accessories segment.
October 11, 2021
Finding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks Earnings ESP.
October 4, 2021
Is Baxter International Inc. (NYSE:BAX) a good place to invest some of your money right now? We can gain invaluable insight to help us answer that question by studying the investment trends of top inv...
October 4, 2021
If you want to know who really controls Baxter International Inc. ( NYSE:BAX ), then you'll have to look at the makeup...
October 1, 2021
NEW YORK, Oct. 01, 2021 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C. announces to investors that it is investigating potential claims on behalf of stockholders of Diversicare Healthcare Services, I...
October 1, 2021
The Zacks Analyst Blog Highlights: Medtronic, Boston Scientific Corp, Catalent, Baxter International and Hill-Rom Holdings
September 30, 2021
MedTech stocks like Boston Scientific (BSX), Catalent (CTLT) and Baxter (BAX) are likely to solidify businesses on the back of impressive M&As.
September 27, 2021
DEERFIELD, Ill., September 27, 2021--Baxter International Inc. (NYSE:BAX), a leading global medical products company, will host a conference call to discuss its third-quarter 2021 financial results on...
September 27, 2021
Baxter's (BAX) norepinephrine can improve speed, efficiency and safety of treatment during critical care situations in hospital settings, and minimize compounding errors or touch contamination risks.
Next page